Lower Urinary Tract Symptoms After Intravesical Therapy
Trial Parameters
Brief Summary
With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.
Eligibility Criteria
Inclusion Criteria: * Urinary bladder carcinoma requiring instillation therapy * Complete resection of the tumor * No intravesical chemotherapy in the last 3 months Exclusion Criteria: * Patients who are unable to complete the questionnaires * Patients who are not willing to participate * Patients with contraindications for instillation therapy (allergic reactions, immunosuppression)